NEW YORK (Medscape Wire) May 22 -- Chemoembolization should be the standard approach in selected patients with unresectable hepatocellular carcinoma, based on improved survival in a randomized ...

This new principle called ‘monocomponent chemoembolization’ showed the first good results in routine intra-arterial chemoembolization of oral cancer patients and will be continued.

March 29, 2004 (Phoenix) — Combination chemoembolization and radiofrequency ablation (RFA) provides good local control of liver tumors up to 6 cm, but the treatment does not prevent metastases ...

Lenvatinib (LEN) is a first-line therapy for patients with advanced hepatocellular carcinoma (HCC); however, it has shown modest survival benefits. Therefore, we aimed to compare clinical outcomes of ...

Diffusion-weighted magnetic resonance imaging to predict response of hepatocellular carcinoma to chemoembolization. World Journal of Gastroenterology, 2010; 16 (25): 3161 DOI: 10.3748/wjg.v16.i25.3161 ...

Combining transarterial chemoembolization (TACE) with lenvatinib (Lenvima) as first-line treatment for advanced hepatocellular carcinoma (HCC) prolonged survival compared with lenvatinib alone ...

According to this report Global Transarterial Chemoembolization (TACE) Market will rise from Covid-19 crisis at moderate growth rate during 2021 to 2028. Transarterial Chemoembolization (TACE) Market ...